| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Graft-versus-Host Disease: Novel Biological Insights
|
Teshima, Takanori
|
|
2016
|
22 |
1 |
p. 11-16
6 p.
|
artikel
|
| 2 |
Adenovirus Viremia in Adult CD34+ Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact
|
Lee, Yeon Joo
|
|
2016
|
22 |
1 |
p. 174-178
5 p.
|
artikel
|
| 3 |
Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes
|
Jindra, Peter T.
|
|
2016
|
22 |
1 |
p. 27-36
10 p.
|
artikel
|
| 4 |
ASBMT News
|
|
|
2016
|
22 |
1 |
p. 190-
1 p.
|
artikel
|
| 5 |
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
|
Efebera, Yvonne A.
|
|
2016
|
22 |
1 |
p. 71-79
9 p.
|
artikel
|
| 6 |
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
|
Gaballa, Sameh
|
|
2016
|
22 |
1 |
p. 141-148
8 p.
|
artikel
|
| 7 |
Blood and Marrow Transplant Handbook
|
Lin, Mei
|
|
2016
|
22 |
1 |
p. 187-188
2 p.
|
artikel
|
| 8 |
Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains
|
Jain, Tania
|
|
2016
|
22 |
1 |
p. 157-163
7 p.
|
artikel
|
| 9 |
Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
|
van Groningen, Lenneke F.J.
|
|
2016
|
22 |
1 |
p. 179-182
4 p.
|
artikel
|
| 10 |
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index
|
Bashey, Asad
|
|
2016
|
22 |
1 |
p. 125-133
9 p.
|
artikel
|
| 11 |
Correspondence Regarding the Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues
|
Churpek, Jane E.
|
|
2016
|
22 |
1 |
p. 183-184
2 p.
|
artikel
|
| 12 |
Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association
|
Bitan, Menachem
|
|
2016
|
22 |
1 |
p. 96-103
8 p.
|
artikel
|
| 13 |
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
|
Ahn, Jae-Sook
|
|
2016
|
22 |
1 |
p. 61-70
10 p.
|
artikel
|
| 14 |
Dynamic Detection of Anti–Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12–Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
|
Pan, Zhijuan
|
|
2016
|
22 |
1 |
p. 86-95
10 p.
|
artikel
|
| 15 |
Editorial Board
|
|
|
2016
|
22 |
1 |
p. A6-
1 p.
|
artikel
|
| 16 |
Ethical Considerations in Pediatric Stem Cell Donation
|
Grilley, Bambi J.
|
|
2016
|
22 |
1 |
p. 3-
1 p.
|
artikel
|
| 17 |
Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies
|
Perales, Miguel-Angel
|
|
2016
|
22 |
1 |
p. 17-22
6 p.
|
artikel
|
| 18 |
Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States
|
Apperley, Jane
|
|
2016
|
22 |
1 |
p. 23-26
4 p.
|
artikel
|
| 19 |
Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor
|
Blaise, Didier
|
|
2016
|
22 |
1 |
p. 119-124
6 p.
|
artikel
|
| 20 |
Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?
|
Robin, Marie
|
|
2016
|
22 |
1 |
p. 1-2
2 p.
|
artikel
|
| 21 |
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
|
Harris, Andrew C.
|
|
2016
|
22 |
1 |
p. 4-10
7 p.
|
artikel
|
| 22 |
Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis
|
Stiff, Patrick J.
|
|
2016
|
22 |
1 |
p. 164-169
6 p.
|
artikel
|
| 23 |
Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell Transplantation
|
Podgorny, Peter J.
|
|
2016
|
22 |
1 |
p. 37-46
10 p.
|
artikel
|
| 24 |
Masthead (Purpose and Scope)
|
|
|
2016
|
22 |
1 |
p. A4-
1 p.
|
artikel
|
| 25 |
New Wine in New Bottle
|
Jethava, Yogesh
|
|
2016
|
22 |
1 |
p. 189-
1 p.
|
artikel
|
| 26 |
Officers and Directors of ASBMT
|
|
|
2016
|
22 |
1 |
p. A8-
1 p.
|
artikel
|
| 27 |
Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child
|
Ullrich, Christina K.
|
|
2016
|
22 |
1 |
p. 104-111
8 p.
|
artikel
|
| 28 |
Pharmacokinetic and Analytical Issues in Busulfan Area Under the Curve Estimation and Simulation
|
Philippe, Michael
|
|
2016
|
22 |
1 |
p. 185-
1 p.
|
artikel
|
| 29 |
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia
|
El-Jawahri, Areej
|
|
2016
|
22 |
1 |
p. 80-85
6 p.
|
artikel
|
| 30 |
Predicted Indirectly ReCognizable HLA Epitopes Class I Promote Antileukemia Responses after Cord Blood Transplantation: Indications for a Potential Novel Donor Selection Tool
|
Thus, Kirsten A.
|
|
2016
|
22 |
1 |
p. 170-173
4 p.
|
artikel
|
| 31 |
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series
|
Pawarode, Attaphol
|
|
2016
|
22 |
1 |
p. 54-60
7 p.
|
artikel
|
| 32 |
Reply to “Pharmacokinetic and Analytical Issues in Busulfan Area Under the Curve Estimation and Simulation”
|
Dupuis, L. Lee
|
|
2016
|
22 |
1 |
p. 186-
1 p.
|
artikel
|
| 33 |
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors
|
Lazaryan, Aleksandr
|
|
2016
|
22 |
1 |
p. 134-140
7 p.
|
artikel
|
| 34 |
Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
|
Johnston, Christine
|
|
2016
|
22 |
1 |
p. 149-156
8 p.
|
artikel
|
| 35 |
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies
|
Jacoby, Elad
|
|
2016
|
22 |
1 |
p. 112-118
7 p.
|
artikel
|
| 36 |
Table of Contents
|
|
|
2016
|
22 |
1 |
p. A11-A15
nvt p.
|
artikel
|
| 37 |
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia
|
Kongtim, Piyanuch
|
|
2016
|
22 |
1 |
p. 47-53
7 p.
|
artikel
|
Tijdschrift beschrijving